summit clinical trial tirzepatide 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality vs sitagliptin, but offered no Retatrutide Phase 3 TRIUMPH-4 Results:

This dual mechanism is why tirzepatide has produced greater weight loss in clinical trials than single-agonist GLP-1 drugs like semaglutide

Weight reduction triggers adaptive changes in hunger and satiety hormones and energy expenditure, which favor weight regain, Neff says

Working with healthcare professionals can help individuals identify the most sustainable and affordable treatment plan

Ozempic, Rybelsus

Your Gut as a Brewery Auto-Brewery Syndrome and the Spectrum of Brain Fog One of the most dramatic illustrations of yeast overgrowth is auto-brewery syndrome a condition where the intestines literally ferment carbohydrates into alcohol